Group One Trading
PCVX icon

Group One Trading’s Vaxcyte PCVX Stock Holding History

Group One Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$618K Buy
+10,632
New +$577K ﹤0.01% 3296
2026
Q1 		– Sell
-831
Closed -$45.1K – 8461
2025
Q4 		$38.3K Buy
+831
New +$37.2K ﹤0.01% 5812
2025
Q1 		– Sell
-4,273
Closed -$342K – 8179
2024
Q4 		$350K Buy
+4,273
New +$424K ﹤0.01% 3469
2024
Q3 		– Sell
-2,473
Closed -$223K – 7182
2024
Q2 		$187K Buy
+2,473
New +$168K ﹤0.01% 3452

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Group One Trading's PCVX Position: Q2 2026 in Review

Group One Trading opened a new position in Vaxcyte (PCVX) in Q2 2026: 10,632 shares worth $618K. The stake represents ﹤0.01% of the portfolio and ranks #3296 among its holdings. This is a return to the name: Group One Trading previously reported a position in PCVX as recently as Q4 2025.

Group One Trading first reported a position in PCVX in Q2 2024 and has held it in 4 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Group One Trading held 10,632 shares of Vaxcyte worth $618K as of Q2 2026.
  • Vaxcyte was a new Group One Trading position in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3296 holding.
  • Group One Trading first reported a position in Vaxcyte in Q2 2024 and has held it in 4 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.